• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prognostic models: rising to the challenge.

作者信息

McCarthy Nicola

出版信息

Nat Rev Cancer. 2013 Jun;13(6):378. doi: 10.1038/nrc3530. Epub 2013 May 3.

DOI:10.1038/nrc3530
PMID:23640208
Abstract
摘要

相似文献

1
Prognostic models: rising to the challenge.预后模型：迎接挑战
Nat Rev Cancer. 2013 Jun;13(6):378. doi: 10.1038/nrc3530. Epub 2013 May 3.
2
Development of a prognostic model for breast cancer survival in an open challenge environment.在开放挑战环境中开发用于乳腺癌生存预测的模型。
Sci Transl Med. 2013 Apr 17;5(181):181ra50. doi: 10.1126/scitranslmed.3005974.
3
Triple negative breast cancer: a heterogeneous subgroup defined by what it is not.
Eur J Cancer. 2011 Sep;47 Suppl 3:S370-2. doi: 10.1016/S0959-8049(11)70207-6.
4
Lost in translation--prognostic signatures for breast cancer.
Nat Clin Pract Oncol. 2008 Jul;5(7):363. doi: 10.1038/ncponc1177.
5
Are all prognostic factors changing with time in breast cancer? - New proposal for classification of prognostic factors as time-dependent and time-independent.
Med Hypotheses. 2005;65(2):413-4. doi: 10.1016/j.mehy.2005.02.011.
6
Breast cancer prognostic markers in the post-genomic era.后基因组时代的乳腺癌预后标志物
Breast Cancer Res Treat. 2011 Feb;125(3):647-50. doi: 10.1007/s10549-010-0932-x. Epub 2010 May 13.
7
Time to move forward from "first-generation" prognostic gene signatures in early breast cancer.
Breast Cancer Res Treat. 2011 Aug;128(3):643-5. doi: 10.1007/s10549-010-1213-4. Epub 2010 Oct 16.
8
Gene signatures of genomic instability as prognostic tools for breast cancer.
Future Oncol. 2011 May;7(5):591-4. doi: 10.2217/fon.11.34.
9
[Prognostic, therapeutic, exploratory tool for carcinogenesis: what is the role of ERBB-2 in breast cancer?].
Ann Pathol. 1999 Apr;19(2):103-15.
10
[Molecular biology of breast carcinoma. Current diagnostic, therapeutic and prognostic aspects].
Zentralbl Chir. 1998;123 Suppl 5:6-12.

引用本文的文献

1
Single-cell analysis reveals the pan-cancer invasiveness-associated transition of adipose-derived stromal cells into COL11A1-expressing cancer-associated fibroblasts.单细胞分析揭示了脂肪组织来源的基质细胞向表达 COL11A1 的癌相关成纤维细胞的泛癌侵袭相关转变。
PLoS Comput Biol. 2021 Jul 20;17(7):e1009228. doi: 10.1371/journal.pcbi.1009228. eCollection 2021 Jul.
2
Pan-cancer driver copy number alterations identified by joint expression/CNA data analysis.联合表达/CNA 数据分析鉴定的泛癌种驱动基因拷贝数改变。
Sci Rep. 2020 Oct 14;10(1):17199. doi: 10.1038/s41598-020-74276-6.
3
as a prognostic marker and its correlation with immune infiltrates in breast cancer.
作为一种预后标志物及其与乳腺癌免疫浸润的相关性。
Aging (Albany NY). 2019 Dec 2;11(23):11124-11135. doi: 10.18632/aging.102514.
4
Expression of FGD3 gene as prognostic factor in young breast cancer patients.FGD3 基因表达作为年轻乳腺癌患者的预后因素。
Sci Rep. 2019 Oct 23;9(1):15204. doi: 10.1038/s41598-019-51766-w.
5
JAK2 expression is associated with tumor-infiltrating lymphocytes and improved breast cancer outcomes: implications for evaluating JAK2 inhibitors.JAK2 表达与肿瘤浸润淋巴细胞相关，并改善乳腺癌结局：评估 JAK2 抑制剂的意义。
Cancer Immunol Res. 2014 Apr;2(4):301-6. doi: 10.1158/2326-6066.CIR-13-0189. Epub 2014 Jan 15.